Cell Models for AD: Lipids and Related Signaling Pathways

AD 细胞模型:脂质和相关信号通路

基本信息

  • 批准号:
    7618395
  • 负责人:
  • 金额:
    $ 115.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-05-01 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The major goal of this Program Project Grant (PPG) is to explore novel and under-studied pathways that contribute to Alzheimer's disease (AD). The decreased neuronal plasticity and cognitive memory loss found in people with AD is associated with chronic oxidative stress and increased production of neurotoxic oligomeric amyloid beta (A?) that cause release of cytokines and other molecules that promote neurodegeneration and chronic inflammation. We believe that devising methods to limit chronic effects of oxidative stress and oligomeric A? production would have profoundly positive consequences for AD patients. Based on promising results in the current grant period, we propose to better understand the mechanisms underlying the effects of oxidative stress and A? in neurons and glial cells, information that will lead to better treatments for prevention of neurodegeneration and chronic inflammation in the AD brain. We will investigate neuroprotective and pro-inflammatory pathways in neurons, glia and brain microvessels using cell and animal models of AD. Three projects will test the hypotheses that: (1) progression of AD involves expression and activation of the cPLA?/sPLA2/NADPH oxidase pathways to induce inflammatory responses in glial cells and impairment of neuronal functions; (2) chronic inflammation in AD is mediated by P2Y2 receptors (P2Y2Rs) for cytokine-like nucleotides in astrocytes and cerebral microvessels through transactivation of integrins and growth factor receptors, and P2Y2Rs mediate neuroprotective APP processing by a different pathway than inflammation; and (3) statins have both cholesterol-independent and -dependent mechanisms of action that are neuroprotective due to drug-induced transcriptional up-regulation of anti-apoptotic Bcl-2 by ET- 1/calcinurin/NFAT-dependent pathways and inhibition of Rac1 geranylgeranylation. Two cores will support the projects: (A) Administrative Core A will oversee progress on the PPG; (B) Cell, Molecular, and Animal Core B will provide standardized preparations of primary cell cultures and transfectants, and transgenic mice, prepare tissue sections, and perform immunohistochemical analyses, Laser Capture Microdissection, microarray screening of gene expression, and molecular biology assays. These collaborative studies should identify novel strategies to control chronic inflammation and neurodegeneration in AD. RELEVANCE: Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which initially involves the parts of the brain that control thought, memory, and language. Up to 4.5 million Americans suffer from AD from which there is no cure.
描述(由申请人提供):该计划项目资助(PPG)的主要目标是探索导致阿尔茨海默病(AD)的新的和未充分研究的途径。在AD患者中发现的神经元可塑性降低和认知记忆丧失与慢性氧化应激和神经毒性寡聚淀粉样蛋白β(A?)导致细胞因子和其他分子的释放,促进神经变性和慢性炎症。我们相信,设计方法来限制氧化应激和低聚A的慢性影响?生产将对AD患者产生深远的积极影响。基于在目前的资助期内有希望的结果,我们建议更好地了解氧化应激和A?在神经元和神经胶质细胞中,这些信息将导致更好的治疗方法,以预防AD大脑中的神经变性和慢性炎症。我们将使用AD的细胞和动物模型研究神经元、神经胶质和脑微血管中的神经保护和促炎通路。 三个项目将检验以下假设:(1)AD的进展涉及cPLA的表达和激活?(2)AD的慢性炎症是由星形胶质细胞和脑微血管中的P2 Y2受体(P2 Y2 Rs)通过整合素和生长因子受体的反式激活介导的,P2 Y2 Rs通过与炎症不同的途径介导神经保护性APP加工;和(3)他汀类药物具有胆固醇非依赖性和胆固醇依赖性的作用机制,由于ET- 1/钙调磷酸酶/NFAT依赖性途径引起的抗凋亡Bcl-2的药物诱导转录上调和Rac 1香叶基香叶基化的抑制,这些作用机制具有神经保护作用。两个核心将支持这些项目:(A)行政核心A将监督PPG的进展;(B)细胞、分子和动物核心B将提供原代细胞培养物和转染子以及转基因小鼠的标准化制备,制备组织切片,并进行免疫组织化学分析、激光捕获显微切割、基因表达的微阵列筛选和分子生物学测定。这些合作研究应该确定新的策略来控制AD的慢性炎症和神经退行性变。 相关性:痴呆症是一种严重影响人进行日常活动能力的大脑疾病。老年人中最常见的痴呆症是阿尔茨海默病(AD),它最初涉及大脑控制思维,记忆和语言的部分。多达450万美国人患有无法治愈的AD。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GRACE Y SUN其他文献

GRACE Y SUN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GRACE Y SUN', 18)}}的其他基金

Satellite Symposium on "Novel Strategies for Intervention in Neurodegenerative Di
“神经退行性疾病干预新策略”卫星研讨会
  • 批准号:
    7749492
  • 财政年份:
    2009
  • 资助金额:
    $ 115.81万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7192127
  • 财政年份:
    2007
  • 资助金额:
    $ 115.81万
  • 项目类别:
PATHOGENESIS OF PHOSPHOLIPASES A2 IN AD
AD 中磷脂酶 A2 的发病机制
  • 批准号:
    7192130
  • 财政年份:
    2006
  • 资助金额:
    $ 115.81万
  • 项目类别:
Conference on Oxidative Mechanisms in Neurodegeneration
神经变性氧化机制会议
  • 批准号:
    6710407
  • 财政年份:
    2004
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell Models for AD: Lipids and Related Signaling Pathways
AD 细胞模型:脂质和相关信号通路
  • 批准号:
    7410043
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell Models for Alzheimer's disease (AD): Lipids and Related Signaling Pathways
阿尔茨海默病 (AD) 细胞模型:脂质和相关信号通路
  • 批准号:
    8530657
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell Models for AD: Lipids and Related Signaling Pathways
AD 细胞模型:脂质和相关信号通路
  • 批准号:
    7822734
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell models for AD:Lipids and related signaling pathways
AD 细胞模型:脂质和相关信号通路
  • 批准号:
    6733559
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell models for AD:Lipids and related signaling pathways
AD 细胞模型:脂质和相关信号通路
  • 批准号:
    6509922
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:
Cell models for AD:Lipids and related signaling pathways
AD 细胞模型:脂质和相关信号通路
  • 批准号:
    6882626
  • 财政年份:
    2001
  • 资助金额:
    $ 115.81万
  • 项目类别:

相似国自然基金

Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    合作创新研究团队
新型手性NAD(P)H Models合成及生化模拟
  • 批准号:
    20472090
  • 批准年份:
    2004
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目

相似海外基金

Application of deep learning and novel survival models to predict MCI-to-AD dementia progression
应用深度学习和新型生存模型预测 MCI 至 AD 痴呆的进展
  • 批准号:
    10725359
  • 财政年份:
    2023
  • 资助金额:
    $ 115.81万
  • 项目类别:
Multilineage DAmFRET to investigate AD/ADRD protein phase behavior in neural tissue models
多谱系 DAmFRET 研究神经组织模型中 AD/ADRD 蛋白相行为
  • 批准号:
    10583428
  • 财政年份:
    2023
  • 资助金额:
    $ 115.81万
  • 项目类别:
Metabolic and neural activity normalization by cerebral blood flow increase in AD/ADRD models
AD/ADRD 模型中脑血流量增加使代谢和神经活动正常化
  • 批准号:
    10657935
  • 财政年份:
    2023
  • 资助金额:
    $ 115.81万
  • 项目类别:
High-speed imaging of cortical and white matter microvascular flow in AD/ADRD models
AD/ADRD 模型中皮质和白质微血管血流的高速成像
  • 批准号:
    10523289
  • 财政年份:
    2022
  • 资助金额:
    $ 115.81万
  • 项目类别:
Innate Immune Responses to SARS-CoV-2 in AD mouse models
AD 小鼠模型中对 SARS-CoV-2 的先天免疫反应
  • 批准号:
    10713817
  • 财政年份:
    2022
  • 资助金额:
    $ 115.81万
  • 项目类别:
Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models
非常规动物模型中 AD 样发病机制的比较单细胞表观基因组分析
  • 批准号:
    10682624
  • 财政年份:
    2021
  • 资助金额:
    $ 115.81万
  • 项目类别:
Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models
非常规动物模型中 AD 样发病机制的比较单细胞表观基因组分析
  • 批准号:
    10281740
  • 财政年份:
    2021
  • 资助金额:
    $ 115.81万
  • 项目类别:
Exploring the Pathophysiology of AD and ADRDs with 3D Asteroid Models
使用 3D 小行星模型探索 AD 和 ADRD 的病理生理学
  • 批准号:
    10459727
  • 财政年份:
    2021
  • 资助金额:
    $ 115.81万
  • 项目类别:
Screening for enhancers of secreted clusterin (sCLU) and evaluation in AD models
分泌型凝聚素 (sCLU) 增强子的筛选和 AD 模型的评估
  • 批准号:
    10195566
  • 财政年份:
    2021
  • 资助金额:
    $ 115.81万
  • 项目类别:
Comparative Single-Cell Epigenomic Analysis of AD-like Pathogenesis in Unconventional Animal Models
非常规动物模型中 AD 样发病机制的比较单细胞表观基因组分析
  • 批准号:
    10478202
  • 财政年份:
    2021
  • 资助金额:
    $ 115.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了